Bank of America CORP /DE/ Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NYSE
Bank of America Corp /DE/ has reported beneficial ownership of 5.2% of NCR Atleos Corp's common stock as of June 30, 2026.
NYSE
Bank of America Corporation has reported a beneficial ownership of 5.8% in Travere Therapeutics, Inc., holding over 5.4 million shares as of June 30, 2026.
NYSE
Bank of America Corporation has filed a Schedule 13G, reporting beneficial ownership of 4.8% of Liberty Live Holdings, Inc. Class A Common Stock as of June 30, 2026.
NYSE
Bank of America Corp /DE/ has filed a Schedule 13G, reporting a 3.7% beneficial ownership in Pebblebrook Hotel Trust as of June 30, 2026.
NYSE
Bank of America Corp /DE/ has updated its Schedule 13G filing, reporting a 4.9% beneficial ownership in Park Hotels & Resorts Inc. common stock as of June 30, 2026.
NYSE
Bank of America Corporation has disclosed a beneficial ownership of 666,596 shares, representing 3.5% of the outstanding common stock of Outset Medical, Inc.
NYSE
Bank of America Corporation /DE/ has disclosed a beneficial ownership of 1,176,889 shares, representing 1.2% of Rezolute, Inc.'s common stock, as of June 30, 2026.
NYSE
Bank of America Corp /DE/ has reported a beneficial ownership of 6.3% in Camping World Holdings, Inc. Class A Common Stock as of June 30, 2026.
NYSE
Bank of America Corp /DE/ has reported a beneficial ownership of 3,170,198 shares, representing 6.5% of Celcuity Inc.'s common stock, as of June 30, 2026.
NYSE
Bank of America Corp /DE/ has filed a Schedule 13G, reporting a 0.8% beneficial ownership in Group 1 Automotive Inc. as of June 30, 2026.
NYSE
Bank of America Corp. has filed a Schedule 13G, reporting a 3.5% beneficial ownership of NETSTREIT Corp. common stock as of June 30, 2026.
NYSE
Bank of America Corp. /DE/ filed an amendment to its Schedule 13G, correcting a previous filing without introducing new ownership information.
NYSE
Bank of America Corporation /DE/ has reported a beneficial ownership of 6.7% in Total Return Securities Fund's common stock as of June 30, 2026.
NYSE
Bank of America Corporation has reported beneficial ownership of 503,914 Class A Ordinary Shares, representing 6.5% of the outstanding shares, in Research Alliance Corp III.
NYSE
Bank of America Corporation /DE/ has reported beneficial ownership of 4,799,384 shares, representing 5.1% of the outstanding common stock in Blackrock Credit Allocation Income Trust.
NYSE
Bank of America Corporation has disclosed a beneficial ownership of 4.0% in MacroGenics Inc., holding 2,556,475 shares.
NYSE
Bank of America Corp /DE/ has updated its beneficial ownership filing for Array Digital Infrastructure, Inc., now holding 1.4% of the company's common shares.
NYSE
Bank of America Corp /DE/ has filed a Schedule 13G, reporting zero shares beneficially owned in U Power Ltd.
NYSE
Bank of America Corporation /DE/ has filed a Schedule 13G, disclosing a beneficial ownership of 19,729 shares, representing 0.5% of M-tron Industries, Inc.'s common stock.
NYSE
Bank of America Corporation has reported beneficial ownership of 5.9% of Inhibrx Biosciences, Inc. common stock as of June 30, 2026.
NYSE
Bank of America Corporation disclosed a beneficial ownership of 5.8% in IREN Ltd's ordinary shares as of June 30, 2026.
NYSE
Bank of America Corp /DE/ has reported beneficial ownership of 4,468,123 shares, representing 6.7% of the common stock of Fulcrum Therapeutics, Inc.
NYSE
Bank of America Corporation has reported a beneficial ownership of 7.0% in CytomX Therapeutics, Inc., holding over 15.1 million shares.
NYSE
Bank of America Corporation and Bank of America N.A. have reported a 0% beneficial ownership stake in Eaton Vance Senior Income Trust following a successful tender offer.
NYSE
Bank of America has reported a 0% beneficial ownership in Eaton Vance Senior Floating-Rate Trust's Auction Rate Preferred shares following a tender offer.
NYSE
Bank of America Corporation filed an amendment to its Schedule 13G to correct its regulatory filing designation regarding its 5% stake in BlackRock Credit Allocation Income Trust.
NYSE
Bank of America Corporation has filed an amendment to its Schedule 13G regarding its 5.8% beneficial ownership stake in NETSTREIT Corp.
NYSE
Bank of America Corporation has filed a Schedule 13G reporting a 5.8% beneficial ownership stake in NETSTREIT Corp. common stock.
NYSE
Bank of America Corporation has filed a Schedule 13G, reporting beneficial ownership of 5.0% of the common stock of Blackrock Credit Allocation Income Trust.
NYSE
Bank of America Corporation has filed a Schedule 13G reporting a 5.1% beneficial ownership stake in MacroGenics, Inc. common stock.